Search
by Joseph Keenan / FiercePharma
2 min read
Hanmi's $200M China plant likely to make branded drugs versus generics
South Korean drug manufacturer Hanmi is building a $200 million manufacturing plant and R&D center in China, though it won't, apparently,...